Ultrasound guided platelet rich plasma or corticosteroid for supraspinatus tendonosis or partial tear: an observational study of clinical outcome

Tirthankar Dasgupta; Mainak Das; Tushar Gogia; Narender Singh; Aashish Tiwary; Vaibhav Verma

doi:10.18203/issn.2455-4510.IntJResOrthop20233555

Authors

Tirthankar Dasgupta Department of Orthopaedic Surgery, Army College of Medical Sciences and Base Hospital, Delhi, India
Mainak Das Department of Orthopaedics, 5 Airforce Hospital, Jorhat, Assam, India
Tushar Gogia Department of Orthopaedic Surgery, Army College of Medical Sciences and Base Hospital, Delhi, India
Narender Singh Department of Orthopaedic Surgery, Army College of Medical Sciences and Base Hospital, Delhi, India
Aashish Tiwary Department of Orthopaedic Surgery, AFMC, Pune, Maharashtra, India
Vaibhav Verma Department of Orthopaedic Surgery, Army College of Medical Sciences and Base Hospital, Delhi, India

DOI:

https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20233555

Keywords:

PRP, Supraspinatus tendonosis, Partial tear supraspinatus, Corticosteroid injection

Abstract

Background: The clinical application of platelet rich plasma (PRP) in rotator cuff tears has increased recently. Many studies have found no difference between placebo controls and PRP and corticosteroids (CS) and some have found more rapid benefits with PRP injections. The present study was undertaken with the objectives to observe and assess efficacies of the two different treatment modalities in terms of symptomatic relief and recovery of ROM and to ascertain the duration of symptom free period and functional improvement on follow up.

Methods: Observational clinical outcome study, conducted at a tertiary care hospital between September 2020 and March 2022 after institute ethical committee clearance. A total of 100 patients, with a positive clinical test for supraspinatus and magnetic resonance imaging (MRI) suggestive of supraspinatus tendinitis were divided to 2 groups and based on whether they received either intra-articular CS or PRP injection under ultrasonography (USG) guidance All patients were followed up at for assessing the outcomes at 6 weeks, 3 months and 6 months from intervention

Results: The clinical outcome of the group receiving the PRP was better than group receiving CS intervention.

Conclusions: PRP should therefore be considered as a viable option to treat supraspinatus tendinopathy/partial tear as it is cheap, readily available modality using patients own blood which is more acceptable to patient and also safe to individual where complications related to corticosteroids anticipated. Ultrasound guided procedure were found to enhance the accuracy of injection.

Metrics

Metrics Loading ...

References

Luime JJ, Koes BW, Hendriksen IJ, Burdorf A, Verhagen AP, Miedema HS, et al. Prevalence and incidence of shoulder pain in the general population; a systematic review. Scand J Rheumatol. 2004;33(2):73-81.

Lewis JS. Rotator cuff tendinopathy: a model for the continuum of pathology and related management. Br J Sports Med. 2010;44(13):918-23.

Shams A, El-Sayed M, Gamal O, Ewes W. Subacromial injection of autologous platelet-rich plasma versus corticosteroid for the treatment of symptomatic partial rotator cuff tears. Eur J Orthop Surg Traumatol. 2016;26(8):837-42.

Diercks R, Bron C, Dorrestijn O, Meskers C, Naber R, de Ruiter T, et al. Guideline for diagnosis and treatment of subacromial pain syndrome: a multidisciplinary review by the Dutch Orthopaedic Association. Acta Orthop. 2014;85(3):314-22.

Ketola S, Lehtinen JT, Arnala I. Arthroscopic decompression not recommended in the treatment of rotator cuff tendinopa¬thy: a final review of a randomised controlled trial at a mini¬mum follow-up of ten years. Bone Joint J. 2017;99:799-805.

Dickinson RN, Ayers GD, Archer KR, Fan R, Page C, Higgins LD, et al. Physical therapy versus natural history in outcomes of rotator cuff tears: the Rotator Cuff Outcomes Workgroup (ROW) cohort study. J Shoulder Elbow Surg. 2019;28(5):833-8.

Lo IK, Denkers MR, More KD, Nelson AA, Thornton GM, Boorman RS. Partial thickness rotator cuff tears: clinical and imaging outcomes and prognostic factors of successful nonoperative treatment. Open Access J Sports Med. 2018;9:191-7.

Lewis J. Rotator cuff related shoulder pain: assessment, manage¬ment and uncertainties. Man Ther. 2016;23:57-68.

Lin MT, Chiang CF, Wu CH, Huang YT, Tu YK, Wang TG. Comparative effectiveness of injection therapies in rotator cuff tendinopathy: a systematic review, pairwise and network me¬ta-analysis of randomized controlled trials. Arch Phys Med Re-habil. 2019;336-49.

Gaujoux-Viala C, Dougados M, Gossec L. Efficacy and safety of steroid injections for shoulder and elbow tendonitis: a meta-analysis of randomised controlled trials. Ann Rheum Dis. 2009;68(12):1843-9.

Dean, BJ, Lostis, E, Oakley, T, Rombach, I, Morrey, ME, Carr, AJ. The risks and benefits of glucocorticoid treatment for tendinopathy: a systematic review of the effects of local glucocorticoid on tendon. Semin Arthritis Rheum. 2014;43(4):570-6.

Desai VS, Camp CL, Boddapati V, Dines JS, Brockmeier SF, Werner BC. Increasing numbers of shoulder corticosteroid in¬jections within a year preoperatively may be associated with a higher rate of subsequent revision rotator cuff surgery. Arthros-copy. 2019;35:45-50.

Mohamadi A, Chan JJ, Claessen FM, Ring D, Chen NC. Corti¬costeroid injections give small and transient pain relief in rota¬tor cuff tendinosis: a meta-analysis. Clin Orthop Relat Res. 2017;475:232-43.

Maman E, Yehuda C, Pritsch T, Morag G, Brosh T, Sharfman Z, et al. Detrimental effect of re¬peated and single subacromial corticosteroid injections on the intact and injured rotator cuff: a biomechanical and imaging study in rats. Am J Sports Med. 2016;44:177-82.

Freire V, Bureau NJ. Injectable corticosteroids: take precautions and use caution. Semin Musculoskelet Radiol. 2016;20:401-8.

Zhang AZ, Ficklscherer A, Gülecyüz MF, Paulus AC, Niethammer TR, Jansson V, et al. Cell toxicity in fi-broblasts, tenocytes, and human mesenchymal stem cells: a comparison of necrosis and apoptosis-inducing ability in ropiv¬acaine, bupivacaine, and triamcinolone. Arthroscopy. 2017;33:840-8.

Ibrahim DH, El-Gazzar NM, El-Saadany HM, El-Khouly RM. Ultrasound-guided injection of platelet rich plasma versus corticosteroid for treatment of rotator cuff tendinopathy: effect on shoulder pain, disability, range of motion and ultrasonographic findings. Egyptian Rheumatol. 2019;41(2):157-61.

Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet- rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27(3):158-67.

Rutgers M, Saris DB, Dhert WJ, Creemers LB. Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection. Arthritis Res Therapy. 2010;12(3):1.

De Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, Tol JL. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010;303(2):144-9.

Jo CH, Lee SY, Yoon KS, Oh S, Shin S. Allogenic pure plate¬let-rich plasma therapy for rotator cuff disease: a bench and bed study. Am J Sports Med. 2018;46:3142-54.

Dadgostar H, Fahimipour F, Pahlevan Sabagh A, Arasteh P, Razi M. Corticosteroids or platelet-rich plasma injections for rotator cuff tendinopathy: a randomized clinical trial study. J Orthop Surg Res. 2021;16(1):1-8.

von Wehren L, Blanke F, Todorov A, Heisterbach P, Sailer J, Ma¬jewski M. The effect of subacromial injections of autologous conditioned plasma versus cortisone for the treatment of symp¬tomatic partial rotator cuff tears. Knee Surg Sports Traumatol Arthrosc. 2016;24:3787-92.

Scarpone M, Rabago D, Snell E, Demeo P, Ruppert K, Pritchard P, et al. Effectiveness of platelet-rich plasma injection for rotator cuff tendinopathy: a prospective open-label study. Glob Adv Health Med. 2013;2(2):26-31.

Kesikburun S, Tan AK, Yılmaz B, Yaşar E, Yazıcıoğlu K. Platelet-rich plasma injections in the treatment of chronic rotator cuff tendinopathy: a randomized controlled trial with 1-year follow-up. Am J Sports Med. 2013;41(11):2609-16.

Puzzitiello RN, Patel BH, Nwachukwu BU, Allen AA, Forsythe B, Salzler MJ. Adverse impact of corticosteroid injection on ro¬tator cuff tendon health and repair: a systematic review. Ar¬throscopy. 2020;36:1468-75.

Haraldsson BT, Langberg H, Aagaard P, Zuurmond AM, van El B, DeGroot J, et al. Corticosteroids reduce the tensile strength of isolated collagen fascicles. Am J Sports Med. 2006;34(12):1992-7.

de Mos M, van der Windt AE, Jahr H, van Schie HT, Weinans H, Verhaar JA, et al. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med. 2008;36(6):1171-8.

Kajikawa Y, Morihara T, Sakamoto H, Matsuda K, Oshima Y, Yoshida A, et al. Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiol. 2008;215(3):837-45.

Louis LJ. Musculoskeletal ultrasound intervention: principles and advances. Radiol Clin. 2008;46:515-33.